EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 104 filers reported holding EPIZYME INC in Q1 2015. The put-call ratio across all filers is 0.96 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,362,000 | -76.7% | 132,000 | -71.6% | 0.35% | -71.3% |
Q2 2019 | $5,836,000 | -5.8% | 465,000 | -7.0% | 1.21% | -25.3% |
Q1 2019 | $6,195,000 | +173.5% | 500,000 | +233.3% | 1.62% | +243.7% |
Q2 2017 | $2,265,000 | -78.0% | 150,000 | -75.0% | 0.47% | -75.4% |
Q1 2017 | $10,290,000 | +79.0% | 600,000 | +26.3% | 1.92% | +38.7% |
Q4 2016 | $5,748,000 | +198.0% | 475,000 | +216.7% | 1.38% | +59.3% |
Q3 2015 | $1,929,000 | -67.8% | 150,000 | -40.0% | 0.87% | -55.3% |
Q2 2015 | $6,000,000 | +38.9% | 250,000 | +8.7% | 1.94% | +150.2% |
Q1 2015 | $4,320,000 | +321.5% | 230,000 | +411.1% | 0.78% | +27.6% |
Q1 2014 | $1,025,000 | – | 45,000 | – | 0.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |